About Quellios
Quellios exists to make inflammation visible and actionable. Our name comes from ‘quell’ – to calm, reduce, and control. We empower people to understand and manage their health by helping them quell inflammation before it takes a toll.
Our Team
Our team brings deep experience in wearable technology and digital health, with more than 200 combined patents and a track record of helping bring over 100 million wearable devices to market. Building on that foundation, we’re working to advance new approaches for understanding inflammation-related patterns in everyday life – starting with digestive wellness.
Dr. Steven LeBoeuf
Cofounder/CEO
Dr. Steven LeBoeuf is an industry-leading biomedical sensing innovator, startup executive, and veteran scientist-entrepreneur of the modern wearables movement. He pioneered motion-tolerant photoplethysmography (PPG) technology for ambulatory monitoring in naturalistic conditions and helped commercialize consumer wearable biomedical sensing for health and wellness applications. Inventor of more than 200 granted patents, LeBoeuf’s innovations can be found in hundreds of millions of products worldwide, spanning consumer and medical markets. He earned a PhD in Solid State Electrical Engineering from North Carolina State University, where he was inducted into the ECE Hall of Fame.
Mark Felice
Cofounder/CCO
With more than 20 years of experience scaling early-stage, venture-backed companies, Mark Felice has led customer acquisition, strategic sales, and revenue growth across AI-driven digital health, medical devices, consumer electronics, and wearable technology markets. As a founder and early commercial leader at multiple startups, Felice has originated, negotiated, and closed multi-million-dollar partnerships with healthcare systems, pharma, medical-device, and consumer-electronics organizations. At Quellios, he leads go-to-market strategy, strategic partnerships, and commercial growth. Felice holds a BS in Electrical Engineering from the University of Michigan.
Dr. Mike Aumer
Cofounder/CTO
Dr. Michael Aumer is an experienced startup executive, technology leader, and innovator in wearable sensing, with deep expertise in bio-optical signal analysis, sensor systems, and biomedical device engineering. He has played a pivotal role in developing biometric sensing technologies for wrist-worn devices, sports earbuds, and hearing health applications. His work spans deep-PPG technology, biomechanical algorithm development, low-power medical diagnostics, real-time physiological monitoring, data science, hardware engineering, semiconductor research, and software development. Dr. Aumer holds a PhD in Electrical Engineering from North Carolina State University and an MSTM from Johns Hopkins University.
Mike Hay
VP Software
Mike Hay is a seasoned software engineering leader and product strategist with more than three decades of experience building high-impact technology products across large companies, startups, and growth-stage teams. His work spans embedded systems, mobile applications, enterprise-scale software, identity and authenticity platforms, and consumer-facing digital products. He has held engineering and software leadership roles at Apple, Adobe, Alitheon, Pocket Prep, Ticketmaster Innovation, MartianCraft, and other technology companies. At Quellios, Hay leads software development, mobile product execution, and the engineering systems needed to deliver practical, scalable digital health experiences.
The Quellios Solution
- Real-time inflammation monitoring – Snap & Sense™ technology uses just your smartphone to track your body’s physiological response to food–no blood tests, no guesswork.
- Personalized dietary profiling – Pinpoint the foods, stresses, and behaviors that trigger inflammation for you–and the ones that help calm it.
- Symptom prevention support – See how your body responds to everyday choices so you can act early and stay ahead of discomfort.
